Latest Dilution News

Page 3 of 282
Terra Critical Minerals has expanded across tungsten, tin and uranium in three mining jurisdictions, but its FY2026 accounts put the funding challenge front and centre. The ASX-listed explorer ended the year with $336,585 in cash and an auditor-flagged material uncertainty over its ability to continue as a going concern.
Maxwell Dee
Maxwell Dee
1 Oct 2026
Xpedra Resources has made Springfield the centrepiece of a sharp shift into New South Wales gold exploration, with drilling outlining broad mineralisation across 400 metres of strike and to at least 150 metres down-dip. The results came alongside a $7.53 million annual loss, $3.09 million in cash and a fresh 44 million-share acquisition of the Neeld Gold Project.
Maxwell Dee
Maxwell Dee
30 Sept 2026
Patriot Resources has established a 31.4 million-ounce silver-equivalent inferred resource at its Tassa project in Peru, but the company's annual report warns that further capital raising is required to sustain operations. The explorer recorded a $4.82 million loss and remains dependent on final drilling approvals.
Maxwell Dee
Maxwell Dee
30 Sept 2026
Buxton Resources has returned to profit after selling its 49% Copper Wolf joint venture interest to IGO for A$5.91 million. The transaction lifted cash and term deposit investments to A$7.39 million, but the explorer remains dependent on capital and future discoveries rather than recurring earnings.
Maxwell Dee
Maxwell Dee
30 Sept 2026
Tasman Resources has swung to a $16.5 million FY2026 profit after booking a $19.48 million gain when Eden Innovations ceased to be controlled. The explorer also ended the year with $5.65 million in cash and no borrowings, but its next test is geological rather than accounting: drilling at Titan West and Parkinson Dam.
Maxwell Dee
Maxwell Dee
30 Sept 2026
Tyranna Resources has reported a A$3.72 million FY2026 loss, A$370,484 in closing cash and an auditor-flagged material uncertainty over its ability to continue as a going concern. The company has since sold its Namibe project, raised A$1 million and committed to a new rare earths earn-in in Angola.
Maxwell Dee
Maxwell Dee
30 Sept 2026
Tusker Minerals reduced its FY2026 loss, but the improvement was driven largely by a A$4.64 million asset-sale gain rather than mining revenue. The early-stage explorer is concentrating its capital on Cameroon rutile and heavy mineral sands while relying on future funding to maintain momentum.
Maxwell Dee
Maxwell Dee
30 Sept 2026
Aldoro Resources has expanded its Kameelburg rare earths, strontium and niobium resource in Namibia to 804.5 million tonnes, including a maiden 162.1Mt Indicated category. The technical progress is substantial, but the annual report also flags a $15.7 million loss, just $78,561 in year-end cash and material uncertainty over ongoing funding.
Maxwell Dee
Maxwell Dee
30 Sept 2026
Streamplay Studio lifted FY26 revenue to A$13.80 million as Noodlecake Studios contributed for a full year, while the statutory loss narrowed and operating cash flow turned positive. The result also highlights falling cash, substantial equity-based compensation and continued reliance on successful game releases.
Victor Sage
Victor Sage
30 Sept 2026
Thrive Tribe Technologies has repositioned WooBoard and REFFIND towards defence and workforce software, but its FY26 annual report flags a material uncertainty over the company’s ability to continue as a going concern. The pivot follows a $3.66 million loss, $2.57 million operating cash outflow and another $1 million placement after year-end.
Sophie Babbage
Sophie Babbage
30 Sept 2026
ION Video has reported a $4.52 million FY2026 loss and a $3.21 million operating cash drain, even as a post-year-end $4.25 million placement lifted its balance sheet. Auditors have preserved their opinion but flagged material uncertainty over the company’s ability to continue as a going concern.
Sophie Babbage
Sophie Babbage
30 Sept 2026
CONNEQT Health delivered sharp FY26 revenue growth and reduced its statutory loss as Pulse sales and clinical subscriptions expanded. But the ASX-listed medtech group ended the year with negative net assets, heavy cash burn and a material uncertainty over its ability to continue as a going concern.
Victor Sage
Victor Sage
30 Sept 2026

Browse the archive

Full archive